青啤(00168.HK)AH股涨10%及9%半年多赚25%获大行升价
青啤(00168.HK)(600600.SH)半年多赚25%,大和及瑞信绩後升青啤H股目标价分别至53元及65元,分别反映公司均价改善毛利扩张及次季业绩胜预期。青啤H股承过去两天升势,今早高见52.4元,创近三个月高,现造52.3元,续升9%,成交增至507万股;其A股扭转昨天整固势,涨10%至停板报50.66元人民币,创逾一个月高,成交急增至1,820万股,创逾四个月高。
青啤公布,按中国会计准则,今年上半年纯利按年增逾25%至16.31亿元人民币(下同),每股盈利1.207元,维持不派中期息。期内,总营收按年升逾9%至165.51亿元。思达克财经新闻
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.